Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
Go back to Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.32 +0.02 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $1.11 | |||
| Open | $2.30 | 52 Week Low | $0.41 | |||
| Day High | $2.36 | P/E | N/A | |||
| Day Low | $2.27 | EPS | $-0.29 | |||
| Volume | 472,794 | |||||

